Published in Arch Intern Med on April 09, 2012
Adherence and the Economics of Colon Cancer Screening | NCT00705731
Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med (2013) 2.96
An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med (2013) 2.89
Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst (2014) 1.61
Increasing colon cancer screening in primary care among African Americans. J Natl Cancer Inst (2014) 1.53
Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointest Endosc (2015) 1.51
Colorectal cancer screening and prevention in women. Dig Dis Sci (2015) 1.46
Navigating the murky waters of colorectal cancer screening and health reform. Am J Public Health (2014) 1.41
Colorectal cancer screening--optimizing current strategies and new directions. Nat Rev Clin Oncol (2013) 1.35
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer (2015) 1.25
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials (2014) 1.19
Colonoscopy for colorectal cancer screening. J Cancer (2013) 1.18
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10
Comparative Effectiveness of Multifaceted Outreach to Initiate Colorectal Cancer Screening in Community Health Centers: A Randomized Controlled Trial. J Gen Intern Med (2015) 1.08
Colorectal cancer. Nat Rev Dis Prim (2015) 1.07
Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. JAMA (2017) 1.05
Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. PLoS One (2014) 1.03
Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol (2014) 1.02
Physician counseling on colorectal cancer screening and receipt of screening among Latino patients. J Gen Intern Med (2015) 0.98
Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med (2016) 0.97
Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med (2013) 0.97
Influence of provider discussion and specific recommendation on colorectal cancer screening uptake among U.S. adults. Prev Med (2014) 0.95
Colorectal cancer disparities: issues, controversies and solutions. World J Gastroenterol (2014) 0.95
Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer. Br J Cancer (2013) 0.94
The Effectiveness of a Physician-Only and Physician-Patient Intervention on Colorectal Cancer Screening Discussions Between Providers and African American and Latino Patients. J Gen Intern Med (2015) 0.92
Molecular markers for colorectal cancer screening. Gut (2015) 0.92
Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Patient trust in physician influences colorectal cancer screening in low-income patients. Am J Prev Med (2014) 0.92
Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med (2014) 0.91
Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system. Cancer (2015) 0.90
Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Cancer (2014) 0.89
Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years. Am J Gastroenterol (2015) 0.89
Development and evaluation of a new survey instrument to measure the quality of colorectal cancer screening decisions. BMC Med Inform Decis Mak (2014) 0.88
Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review. Prev Med (2014) 0.88
Reducing Colorectal Cancer Risk Among African Americans. Gastroenterology (2015) 0.88
The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? Clin Gastroenterol Hepatol (2013) 0.87
Barriers to colorectal cancer screening among women in rural central Pennsylvania: primary care physicians' perspective. Rural Remote Health (2013) 0.85
Physicians, clinics, and neighborhoods: multiple levels of influence on colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2014) 0.84
Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process. BMC Health Serv Res (2015) 0.84
The effects of test preference, test access, and navigation on colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2014) 0.83
Colorectal cancer screening: what do women from diverse ethnic groups want? J Gen Intern Med (2012) 0.83
Using a discrete choice experiment to inform the design of programs to promote colon cancer screening for vulnerable populations in North Carolina. BMC Health Serv Res (2014) 0.82
Barriers and facilitators to colorectal cancer screening in Vietnamese Americans: a qualitative analysis. J Cancer Educ (2014) 0.82
Equity and practice issues in colorectal cancer screening: Mixed-methods study. Can Fam Physician (2016) 0.81
Perceived barriers and facilitators of using a Web-based interactive decision aid for colorectal cancer screening in community practice settings: findings from focus groups with primary care clinicians and medical office staff. J Med Internet Res (2013) 0.80
The importance of choosing colorectal cancer screening tests: comment on "Adherence to colorectal cancer screening". Arch Intern Med (2012) 0.80
Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study. BMC Public Health (2015) 0.79
Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial. Med Decis Making (2016) 0.79
Crafting Appealing Text Messages to Encourage Colorectal Cancer Screening Test Completion: A Qualitative Study. JMIR Mhealth Uhealth (2015) 0.79
Older adults' preferences for colorectal cancer-screening test attributes and test choice. Patient Prefer Adherence (2015) 0.79
Managed care patients' preferences, physician recommendations, and colon cancer screening. Am J Manag Care (2014) 0.79
Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening. J Natl Compr Canc Netw (2016) 0.79
Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol (2016) 0.79
Colorectal Cancer Screening in US Seniors Ages 76-84 Years. J Community Health (2015) 0.78
Colorectal Cancer in African Americans: An Update. Clin Transl Gastroenterol (2016) 0.78
Multilevel predictors of colorectal cancer testing modality among publicly and privately insured people turning 50. Prev Med Rep (2016) 0.77
"BeneFITs" to increase colorectal cancer screening in priority populations. JAMA Intern Med (2014) 0.77
Patient Decision Aids for Colorectal Cancer Screening: A Systematic Review and Meta-analysis. Am J Prev Med (2016) 0.77
Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med (2016) 0.77
Pathways to colonoscopy in the South: seeds of health disparities. Am J Public Health (2015) 0.76
Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System. Am J Gastroenterol (2016) 0.76
Late presentation of colorectal cancer in a vulnerable population. Am J Gastroenterol (2013) 0.76
Colorectal cancer development and advances in screening. Clin Interv Aging (2016) 0.76
Race/Ethnicity and Primary Language: Health Beliefs about Colorectal Cancer Screening in a Diverse, Low-Income Population. J Health Care Poor Underserved (2015) 0.75
Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities. Gut Liver (2016) 0.75
Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines. World J Gastrointest Oncol (2016) 0.75
Recruiting community health centers into pragmatic research: Findings from STOP CRC. Clin Trials (2015) 0.75
Male Role Norms, Knowledge, Attitudes, and Perceptions of Colorectal Cancer Screening among Young Adult African American Men. Front Public Health (2014) 0.75
Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. Am J Gastroenterol (2016) 0.75
Outreach and Inreach Organized Service Screening Programs for Colorectal Cancer. PLoS One (2016) 0.75
Patient and Provider Preferences for Colorectal Cancer Screening: How Does CT Colonography Compare to Other Modalities? Int J Canc Prev (2011) 0.75
Predictors of primary care provider adoption of CT colonography for colorectal cancer screening. Abdom Radiol (2016) 0.75
Fecal immunochemical test for colorectal cancer from a prospective cohort with 513,283 individuals: Providing detailed number needed to scope (NNS) before colonoscopy. Medicine (Baltimore) (2016) 0.75
Rural-Urban Differences in Colorectal Cancer Screening Barriers in Nebraska. J Community Health (2015) 0.75
Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study. Scand J Gastroenterol (2016) 0.75
Polyp detection rate and pathological features in patients undergoing a comprehensive colonoscopy screening. World J Gastrointest Pathophysiol (2017) 0.75
Tissue resonance interaction accurately detects colon lesions: A double-blind pilot study. World J Gastroenterol (2015) 0.75
Colonoscopy Screening among Native Hawaiians at Queen's Medical Center between August 2011 and January 2013. Hawaii J Med Public Health (2016) 0.75
Colorectal Cancer Screening and Chinese Americans: Efficacy of Lay Health Worker Outreach and Print Materials. Am J Prev Med (2016) 0.75
Adherence to Screening Colonoscopy: Can We Get Our Recommendations to Stick? Dig Dis Sci (2015) 0.75
Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World J Gastroenterol (2017) 0.75
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2017) 0.75
Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data. Dig Dis Sci (2017) 0.75
Colorectal Cancer Screening in Asia. Curr Gastroenterol Rep (2017) 0.75
The Association Between Primary Source of Healthcare Coverage and Colorectal Cancer Screening Among US Veterans. Dig Dis Sci (2017) 0.75
A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer (2017) 0.75
Colorectal Cancer Screening in Vulnerable Patients: Promoting Informed and Shared Decisions. Am J Prev Med (2016) 0.75
Colorectal cancer screening: An updated review of the available options. World J Gastroenterol (2017) 0.75
Evaluation of the Knowledge Levels of 50-Year-Old and Older Individuals Regarding Colorectal Cancer. J Cancer Educ (2017) 0.75
Optimizing the Quality of the Colorectal Cancer Screening Continuum: A Call to Action. J Natl Cancer Inst (2017) 0.75
Colon PillCam: why not just take a pill? Dig Dis Sci (2015) 0.75
Development of a Practical Model for Targeting Patient Decision Support Interventions to Promote Colorectal Cancer Screening in Vulnerable Populations. J Health Care Poor Underserved (2016) 0.75
Stool Based Testing for Colorectal Cancer: an Overview of Available Evidence. Curr Gastroenterol Rep (2017) 0.75
Hypermethylated DNA, a circulating biomarker for colorectal cancer detection. PLoS One (2017) 0.75
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med (1993) 27.80
Effective physician-patient communication and health outcomes: a review. CMAJ (1995) 25.62
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med (1993) 21.18
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet (1996) 20.53
Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet (1996) 18.89
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 15.50
The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16
A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med (1992) 10.70
Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.65
Understanding the Hispanic paradox. Ethn Dis (2001) 6.75
Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer (2004) 6.41
Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst (1992) 6.18
Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med (1995) 5.59
Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology (2007) 3.78
Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med (1995) 3.54
Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med (2001) 2.87
Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst (2005) 2.51
Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol (2003) 2.43
Medical decision making in situations that offer multiple alternatives. JAMA (1995) 2.19
Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med (2005) 1.94
Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med (1993) 1.82
The psychology of doing nothing: forms of decision avoidance result from reason and emotion. Psychol Bull (2003) 1.80
Does physician communication influence older patients' diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci (2007) 1.80
Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med (2010) 1.42
Explaining disparities in colorectal cancer screening among five Asian ethnic groups: a population-based study in California. BMC Cancer (2010) 1.33
Is discussion of colorectal cancer screening options associated with heightened patient confusion? Cancer Epidemiol Biomarkers Prev (2010) 1.15
Lying to insurance companies: the desire to deceive among physicians and the public. Am J Bioeth (2004) 8.49
Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med (2004) 6.86
Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60
Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA (2007) 5.60
The value of medical spending in the United States, 1960-2000. N Engl J Med (2006) 5.38
Diabetes control with reciprocal peer support versus nurse care management: a randomized trial. Ann Intern Med (2010) 5.18
The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med (2002) 4.79
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med (2012) 4.51
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog (2013) 4.05
Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med (2003) 3.81
Lessons from the mammography wars. N Engl J Med (2010) 3.68
Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol (2005) 3.65
Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med (2006) 3.50
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials (2010) 3.45
The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med (2003) 3.32
The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care (2005) 3.11
Are bad outcomes from questionable clinical decisions preventable medical errors? A case of cascade iatrogenesis. Ann Intern Med (2002) 3.07
Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med (2007) 3.05
Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med (2007) 3.03
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
Validation of the Subjective Numeracy Scale: effects of low numeracy on comprehension of risk communications and utility elicitations. Med Decis Making (2007) 2.89
Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care (2003) 2.88
Patients, privacy and trust: patients' willingness to allow researchers to access their medical records. Soc Sci Med (2006) 2.86
Building a better quality measure: are some patients with 'poor quality' actually getting good care? Med Care (2003) 2.85
Can a disease self-management program reduce health care costs? The case of older women with heart disease. Med Care (2003) 2.78
Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer. Health Serv Res (2005) 2.75
Accepting critically ill transfer patients: adverse effect on a referral center's outcome and benchmark measures. Ann Intern Med (2003) 2.75
Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med (2004) 2.73
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood (2013) 2.72
Clinical implications of numeracy: theory and practice. Ann Behav Med (2008) 2.69
Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health Serv Res (2002) 2.68
Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med (2005) 2.60
When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make? J Gen Intern Med (2003) 2.51
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med (2013) 2.47
Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation (2008) 2.45
The impact of the format of graphical presentation on health-related knowledge and treatment choices. Patient Educ Couns (2008) 2.42
Optimizing statin treatment for primary prevention of coronary artery disease. Ann Intern Med (2010) 2.41
Case management for patients with poorly controlled diabetes: a randomized trial. Am J Med (2004) 2.41
Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol (2004) 2.39
Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens. J Gen Intern Med (2005) 2.32
Personalized estimates of benefit from preventive care guidelines: a proof of concept. Ann Intern Med (2013) 2.29
Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol (2006) 2.27
Predictors of physician career satisfaction, work-life balance, and burnout. Obstet Gynecol (2007) 2.25
Use of the Internet and ratings of information sources for medical decisions: results from the DECISIONS survey. Med Decis Making (2010) 2.25
An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ (2010) 2.22
Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology (2008) 2.20
The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health (2006) 2.20
Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst (2009) 2.18
Latina patient perspectives about informed treatment decision making for breast cancer. Patient Educ Couns (2008) 2.17
Uninsured adults presenting to US emergency departments: assumptions vs data. JAMA (2008) 2.15
Correlates of between-surgeon variation in breast cancer treatments. Med Care (2006) 2.08
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog (2013) 2.06
Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med (2010) 2.06
Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care (2010) 2.05
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00
In the clinic. Type 2 diabetes. Ann Intern Med (2015) 2.00
A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology (2009) 1.95
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology (2008) 1.95
Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med (2011) 1.92
Using benefit-based tailored treatment to improve the use of antihypertensive medications. Circulation (2013) 1.89
An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns (2006) 1.87
Patterns and correlates of patient referral to surgeons for treatment of breast cancer. J Clin Oncol (2007) 1.84
How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services? Diabetes Care (2003) 1.81
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A (2013) 1.80
Does physician communication influence older patients' diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci (2007) 1.80
Correlates of breast reconstruction: results from a population-based study. Cancer (2005) 1.79
Performance measurement in search of a path. N Engl J Med (2007) 1.78
The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol (2009) 1.73
The impact of diabetes on workforce participation: results from a national household sample. Health Serv Res (2004) 1.70
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood (2012) 1.69
Specialty care and the patient-centered medical home. Med Care (2011) 1.68
Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation (2007) 1.68
Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res (2005) 1.67
Alternate methods of framing information about medication side effects: incremental risk versus total risk of occurrence. J Health Commun (2008) 1.65
Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care (2005) 1.64
Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. J Clin Oncol (2012) 1.63
What causes pregnancy loss? Preexisting mental illness as an independent risk factor. Gen Hosp Psychiatry (2007) 1.63
The DECISIONS study: a nationwide survey of United States adults regarding 9 common medical decisions. Med Decis Making (2010) 1.63
Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst (2014) 1.61
All-or-nothing treatment targets make bad performance measures. Am J Manag Care (2007) 1.61
Marriage and cohabitation outcomes after pregnancy loss. Pediatrics (2010) 1.61
Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. Patient Educ Couns (2008) 1.60
New diabetes HEDIS blood pressure quality measure: potential for overtreatment. Am J Manag Care (2010) 1.60
Reporting clinical trial results to inform providers, payers, and consumers. Health Aff (Millwood) (2005) 1.57
Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study. J Clin Oncol (2009) 1.56
Informing the uninformed: optimizing the consent message using a fractional factorial design. JAMA Pediatr (2013) 1.55
Rethinking the objectives of decision aids: a call for conceptual clarity. Med Decis Making (2007) 1.54
When there is too much to do: how practicing physicians prioritize among recommended interventions. J Gen Intern Med (2004) 1.53